Joincare Pharmaceutical Group Industry Co., Ltd
Clinical trials sponsored by Joincare Pharmaceutical Group Industry Co., Ltd, explained in plain language.
-
New COPD pill aims to cut Flare-Ups in half
Disease control Recruiting nowThis study tests whether a daily pill called JKN2403 can reduce serious flare-ups and improve quality of life in people with moderate-to-severe COPD. About 120 adults will take either the drug or a placebo for 24 weeks, with regular clinic visits and symptom diaries. The goal is …
Phase: PHASE2 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New antibiotic JKN2501 enters first human tests
Disease control Recruiting nowThis early-phase trial tests the safety and tolerability of a new antibiotic called JKN2501 in 66 healthy adults in China. Participants receive either the drug or a placebo by IV infusion, and researchers monitor for side effects and how the drug moves through the body. The goal …
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New Single-Dose flu drug for kids shows promise in trial
Symptom relief Recruiting nowThis study tests a new medicine called JKN2301 for children aged 2 to 11 with the flu. It is a single-dose treatment compared to the standard 5-day oseltamivir (Tamiflu) course. The goal is to see if it safely reduces flu symptoms and fever faster. About 177 children will take pa…
Phase: PHASE3 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC